Last reviewed · How we verify
NCT02222389
Contingency Management for the Treatment of Co-Occurring Alcohol and Drug Misuse
NA trial testing CM for Alcohol in Co-Occurring Alcohol and Drug Misuse in 120 participants. Completed in 10 September 2018.
10 September 2018
Quick facts
| Lead sponsor | Washington State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 1 June 2015 |
| Primary completion | 10 September 2018 |
| Estimated completion | 10 September 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- CM for Alcohol
- CM for drugs
- CM for both substances
- Non-Contingent group
Conditions studied
- Co-Occurring Alcohol and Drug Misuse — all drugs for Co-Occurring Alcohol and Drug Misuse →
Sponsor
Washington State University
Who can join
18 and older, any sex, with Co-Occurring Alcohol and Drug Misuse. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Contingency management (CM) is a type of treatment used in the substance abuse field. Patients' behaviors are rewarded for adherence to a treatment plan. As an approach to treatment, contingency management emerged from the behavior therapy traditions in mental health. By most evaluations, contingency management procedures produce one of the largest effect sizes out of all mental health and educational interventions. The purpose of this study is to perform a randomized, controlled trial to evaluate the ability of a culturally-tailored contingency management (CM) intervention to increase alcohol and drug abstinence among American Indian (AI) tribal members from two rural reservations in the Northwest.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The rewarding recovery study: a randomized controlled trial of incentives for alcohol and drug abstinence with a rural American Indian community.
McDonell MG, Skalisky J, Burduli E, Foote A, et al · · 2021 · cited 22× · PMID 33220122 · DOI 10.1111/add.15349
Verify or expand the search:
- PubMed search for NCT02222389
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Washington State University trials
Trials by the same sponsor.
- NCT07088237 — Testing a Music Listening mHealth Intervention for Stress Reduction in Early Recovery (CalmiFy II) · NA · not yet recruiting
- NCT07393672 — Effects of Hemp-Derived Cannabinoids on Menopause Symptoms · Phase 2 · recruiting
- NCT07171359 — TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD) · NA · not yet recruiting
- NCT07052318 — Developing a Music Listening mHealth Intervention for Stress Reduction in Early Recovery · recruiting
- NCT06804239 — Improving Activity in Adults With Chronic Pain With Online Resources · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02222389 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Washington State University
- Last refreshed: 18 September 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02222389.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing